Skip to main content
Livermore
Livermore
ZHEN

Commonwealth Equity Services, LLC

SEC CIK
0000312272
Latest filing
Jul 29, 2026

AVXL holding history

Anavex Life Sciences Corp. in every 13F filed by Commonwealth Equity Services, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

AVXL overviewAll 13F holders of AVXLFull Q2 2026 holdings

Shares (Q2 2026)
0
Sold out in Q2 2026
Value
$0
% of portfolio
0.0%
Quarters held
21
Since Q1 2021
Holdings of AVXL by Commonwealth Equity Services, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20260$00.0%−10,513−100.0%Sold outHolders
Q1 202610,513$32.3K<0.1%+24+0.2%AddedHolders
Q4 202510,489$37.3K<0.1%−96,778−90.2%ReducedHolders
Q3 2025107,267$955.0K<0.1%−6,245−5.5%ReducedHolders
Q2 2025113,512$1.05M<0.1%+1,852+1.7%AddedHolders
Q1 2025111,660$958.0K<0.1%+8,998+8.8%AddedHolders
Q4 2024102,662$1.10M<0.1%+7,285+7.6%AddedHolders
Q3 202495,377$542.0K<0.1%+844+0.9%AddedHolders
Q2 202494,533$399.0K<0.1%+963+1.0%AddedHolders
Q1 202493,570$476.0K<0.1%+1,780+1.9%AddedHolders
Q4 202391,790$855.0K<0.1%+8,557+10.3%AddedHolders
Q3 202383,233$545.0K<0.1%−4,762−5.4%ReducedHolders
Q2 202387,995$715.0K<0.1%+225+0.3%AddedHolders
Q1 202387,770$752.0K<0.1%−3,245−3.6%ReducedHolders
Q4 202291,015$842.0K<0.1%+8,640+10.5%AddedHolders
Q3 202282,375$850.0K<0.1%+285+0.3%AddedHolders
Q2 202282,090$821.0K<0.1%+2,250+2.8%AddedHolders
Q1 202279,840$982.0K<0.1%+5,416+7.3%AddedHolders
Q4 202174,424$1.29M<0.1%+32,109+75.9%AddedHolders
Q3 202142,315$759.0K<0.1%+546+1.3%AddedHolders
Q2 202141,769$954.0K<0.1%+4,340+11.6%AddedHolders
Q1 202137,429$559.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.